结构方程模型验证「控制肠道过度生长」在预防ICU获得性革兰阴性感染中的作用
本研究基于「控制肠道过度生长」(COGO)概念构建7个候选广义结构方程模型,纳入超过200项感染预防研究的数据,分析局部抗生素预防、肠道外抗生素预防、消毒干预等方法对假单胞菌和不动杆菌菌血症及呼吸机相关性肺炎的影响。结果显示消毒干预对假单胞菌肠道过度生长有最强负向效应,但对不动杆菌无显著负向干预;方案化肠道外抗生素预防和同期对照在模型中均呈正向效应,肠道抗生素预防为中性;局部抗生素预防研究中不动杆菌菌血症发生率异常高,且与方案化肠道外抗生素预防暴露相关。 paradoxically,局部抗生素预防对总体菌血症和总体VAP的汇总预防效应最强。结论认为结构方程模型可检验COGO概念,但不动杆菌和假单胞菌菌血症在局部抗生素预防研究中异常高的现象形成悖论。
要点
- 在模拟假单胞菌肠道过度生长为潜变量时,消毒干预具有最强负向效应,但无干预对不动杆菌肠道过度生长呈显著负向效应。
- 方案化肠道外抗生素预防和同期对照在模型中均呈正向效应,肠道抗生素预防为中性。
- 局部抗生素预防研究中不动杆菌菌血症发生率异常高,方案化肠道外抗生素预防暴露时更高。
- 悖论性地,局部抗生素预防(尤其是联合方案化肠道外抗生素预防)对总体菌血症和总体VAP的汇总预防效应最强。
- 结构方程模型可基于已发表革兰阴性杆菌感染数据检验COGO概念。
适用人群与场景
- 数据来源于超过200项感染预防研究,涉及接受机械通气的ICU患者、创伤ICU患者,暴露包括局部抗生素预防、肠道外抗生素预防、消毒干预等。
研究设计与关键结果
- 研究类型为基于已发表数据的结构方程模型分析,纳入超过200项感染预防研究,以假单胞菌和不动杆菌菌血症及呼吸机相关性肺炎数据为结局。
- 在模拟假单胞菌和不动杆菌肠道过度生长为潜变量时,消毒干预对假单胞菌肠道过度生长有最强负向效应,但无干预对不动杆菌肠道过度生长呈显著负向效应。
- 方案化肠道外抗生素预防和同期对照在模型中均呈正向效应,肠道抗生素预防为中性。
- 局部抗生素预防研究中不动杆菌菌血症发生率异常高,方案化肠道外抗生素预防暴露时更高。
- 局部抗生素预防(尤其是联合方案化肠道外抗生素预防)对总体菌血症和总体VAP的汇总预防效应最强。
证据类型、等级与局限
- 证据类型为基于已发表研究的结构方程模型分析;原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为结构方程模型可检验「控制肠道过度生长」概念,但局部抗生素预防研究中不动杆菌和假单胞菌菌血症发生率异常高形成悖论,提示需进一步理解局部抗生素预防与不动杆菌菌血症高发的关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Conceptually, the "control of gut overgrowth" (COGO) is key in mediating prevention against infection with Gram-negative bacilli by topical antibiotic prophylaxis, a common constituent of selective digestive decontamination (SDD) regimens. However, the relative importance of the other SDD components, enteral and protocolized parenteral antibiotic prophylaxis, versus other methods of infection prevention and versus other contextual exposures cannot be resolved within individual studies.
METHODS: Seven candidate generalized structural equation models founded on COGO concepts were confronted with Pseudomonas and Acinetobacter bacteremia as well as ventilator-associated pneumonia data derived from > 200 infection prevention studies. The following group-level exposures were included in the models: use and mode of antibiotic prophylaxis, anti-septic and non-decontamination methods of infection prevention; proportion receiving mechanical ventilation; trauma ICU; mean length of ICU stay; and concurrency versus non-concurrency of topical antibiotic prophylaxis study control groups.
RESULTS: In modeling Pseudomonas and Acinetobacter gut overgrowth as latent variables, anti-septic interventions had the strongest negative effect against Pseudomonas gut overgrowth but no intervention was significantly negative against Acinetobacter gut overgrowth. Strikingly, protocolized parenteral antibiotic prophylaxis and concurrency each have positive effects in the model, enteral antibiotic prophylaxis is neutral, and Acinetobacter bacteremia incidences are high within topical antibiotic prophylaxis studies, moreso with protocolized parenteral antibiotic prophylaxis exposure. Paradoxically, topical antibiotic prophylaxis (moreso with protocolized parenteral antibiotic prophylaxis) appears to provide the strongest summary prevention effects against overall bacteremia and overall VAP.
CONCLUSIONS: Structural equation modeling of published Gram-negative bacillus infection data enables a test of the COGO concept. Paradoxically, Acinetobacter and Pseudomonas bacteremia incidences are unusually high among studies of topical antibiotic prophylaxis.
参考来源
- Hurley JC. Structural equation modeling the "control of gut overgrowth" in the prevention of ICU-acquired Gram-negative infection. Crit Care. 2020. PMID: 32366267. doi:10.1186/s13054-020-02906-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。